NO20014149L - Nye dipeptidforbindelser og deres anvendelse som medisiner - Google Patents

Nye dipeptidforbindelser og deres anvendelse som medisiner

Info

Publication number
NO20014149L
NO20014149L NO20014149A NO20014149A NO20014149L NO 20014149 L NO20014149 L NO 20014149L NO 20014149 A NO20014149 A NO 20014149A NO 20014149 A NO20014149 A NO 20014149A NO 20014149 L NO20014149 L NO 20014149L
Authority
NO
Norway
Prior art keywords
medicines
dipeptide compounds
new dipeptide
new
compounds
Prior art date
Application number
NO20014149A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014149D0 (no
Inventor
Tsutomu Mimoto
Keisuke Terashima
Haruo Takaku
Shinji Matsumoto
Makoto Shintani
Satoshi Nojima
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Publication of NO20014149D0 publication Critical patent/NO20014149D0/no
Publication of NO20014149L publication Critical patent/NO20014149L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO20014149A 1999-12-28 2001-08-27 Nye dipeptidforbindelser og deres anvendelse som medisiner NO20014149L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP37447899 1999-12-28
PCT/JP2000/009361 WO2001047948A1 (fr) 1999-12-28 2000-12-28 Nouveau composé dipeptidique et ses applications en médecine

Publications (2)

Publication Number Publication Date
NO20014149D0 NO20014149D0 (no) 2001-08-27
NO20014149L true NO20014149L (no) 2001-10-23

Family

ID=18503920

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014149A NO20014149L (no) 1999-12-28 2001-08-27 Nye dipeptidforbindelser og deres anvendelse som medisiner

Country Status (7)

Country Link
EP (1) EP1157997A4 (fr)
AU (1) AU779356B2 (fr)
CA (1) CA2362849A1 (fr)
NO (1) NO20014149L (fr)
NZ (1) NZ514017A (fr)
WO (1) WO2001047948A1 (fr)
ZA (1) ZA200106527B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005029470A (ja) * 2001-06-21 2005-02-03 Japan Energy Electronic Materials Inc 新規ノルスタチン誘導体
JP2006076882A (ja) * 2002-09-13 2006-03-23 Sumitomo Pharmaceut Co Ltd 新規なジペプチド化合物及びその医薬用途
WO2005026114A1 (fr) * 2003-09-17 2005-03-24 Pfizer Inc. Inhibiteurs de la protease du vih, compositions les contenant et leurs utilisations pharmaceutiques
US12083099B2 (en) 2020-10-28 2024-09-10 Accencio LLC Methods of treating symptoms of coronavirus infection with viral protease inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3408379B2 (ja) * 1995-06-30 2003-05-19 株式会社ジャパンエナジー 新規なジペプチド化合物又はその薬理的に許容される塩及びその医薬用途
US5932550A (en) * 1995-06-30 1999-08-03 Japan Energy Corporation Dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
JPH11286478A (ja) * 1998-04-01 1999-10-19 Sankyo Co Ltd Ａｈｐｂａ誘導体を含むジペプチド化合物

Also Published As

Publication number Publication date
EP1157997A1 (fr) 2001-11-28
ZA200106527B (en) 2002-10-21
WO2001047948A1 (fr) 2001-07-05
NZ514017A (en) 2003-10-31
EP1157997A4 (fr) 2002-05-08
AU779356B2 (en) 2005-01-20
NO20014149D0 (no) 2001-08-27
CA2362849A1 (fr) 2001-07-05
AU2404101A (en) 2001-07-09

Similar Documents

Publication Publication Date Title
NO20030302L (no) Nye heteroarylderivater og deres anvendelse som medikamenter
NO20015113L (no) Nye forbindelser, deres fremstilling og anvendelse
NO20014135D0 (no) Nye sulfonamidforbindelser og deres anvendelse
NO20030298L (no) Nye heteroarylderivater og deres anvendelse som farmasöytiske midler
NO20030301D0 (no) Nye heteroarylderivater og anvendelse derav som farmasöytika
NO20014225D0 (no) Nye sykliske tetrapeptidderivater og anvendelse derav som legemidler
DK0911340T3 (da) Substituerede isoquinolin-3-carboxylsyreamider, deres fremstilling og deres anvendelse som lægemiddel
NO20040680L (no) Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel
NO20014702D0 (no) Diarylderivater og deres anvendelse som medikamenter
NO20025357L (no) Antranylamider og deres anvendelse som legemidler
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
NO20002486D0 (no) Sykliske aminderivater og deres anvendelse som legemidler
NO20006029D0 (no) Pyrazolinderivater, deres fremstilling og anvendelse som legemidler
NO996313D0 (no) Nye amidinoderivater og deres anvendelse som trombininhibitorer
NO20052124D0 (no) Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse
DK1237857T3 (da) Nye Phenalkyloxyphenylderivater
NO20030382L (no) Nye indolderivater og deres anvendelse som medikamenter
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
DK1150996T3 (da) Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer
NO20035328D0 (no) Nye forbindelser og preparater som katepsinhibitorer
NO20015058L (no) Nye ribose-substituerte aromatiske amider, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
DK1214302T3 (da) Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere
NO20014149D0 (no) Nye dipeptidforbindelser og deres anvendelse som medisiner
DK1200409T3 (da) Substituerede isoquinolinderivater og deres anvendelse som krampestillende midler
NO20020404D0 (no) Streptograminderivater, deres produksjon og forbindelser derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application